Skip to main content
Erschienen in: European Journal of Nutrition 6/2017

03.03.2017 | Review

Nutrition for diabetic retinopathy: plummeting the inevitable threat of diabetic vision loss

verfasst von: Yashodhara Sharma, Sandeep Saxena, Arvind Mishra, Anita Saxena, Shankar Madhav Natu

Erschienen in: European Journal of Nutrition | Ausgabe 6/2017

Einloggen, um Zugang zu erhalten

Abstract

Diabetic retinopathy (DR) is among the leading causes of preventable blindness. Hyperglycemia, hypertension, hyperlipidemia and anemia majorly predispose its pathogenesis. The current treatment modalities of DR include laser photocoagulation therapy, intravitreal corticosteroids, intravitreal anti-vascular endothelial growth factor (VEGF) agents and vitreo-retinal surgery which are costly, highly invasive, unproven for prolonged use and opted in advanced stages of DR. By then retina already encounters a vast damage. Nutrients by their natural physiological, biochemical and molecular action can preserve retinal structure and functions by interfering with the various pathological steps prompting DR incidence, thereby altering the risk of developing this ocular morbidity. Nutrients can also play a central role in DR patients resistant towards the conventional medical treatments. However due to the byzantine interplay existing between nutrients and DR, the worth of nutrition in curbing this vision-threatening ocular morbidity remains silent. This review highlights how nutrients can halt DR development. A nutritional therapy, if adopted in the initial stages, can provide superior-efficacy over the current treatment modalities and can be a complementary, inexpensive, readily available, anodyne option to the clinically unmet requirement for preventing DR. Assessment of nutritional status is presently considered relevant in various clinical conditions except DR. Body Mass Index (BMI) conferred inconclusive results in DR subjects. Subjective Global Assessment (SGA) of nutritional status has recently furnished relevant association with DR status. By integrating nutritional strategies, the risk of developing DR can be reduced substantially. This review summarizes the subsisting knowledge on nutrition, potentially beneficial for preventing DR and sustaining good vision among diabetic subjects.
Literatur
1.
Zurück zum Zitat Song MK, Roufogalis BD, Huang THW (2012) Modulation of diabetic retinopathy pathophysiology by natural medicines through PPAR-γ- related pharmacology. Br J Pharmacol 165:4–19CrossRef Song MK, Roufogalis BD, Huang THW (2012) Modulation of diabetic retinopathy pathophysiology by natural medicines through PPAR-γ- related pharmacology. Br J Pharmacol 165:4–19CrossRef
2.
Zurück zum Zitat Rani PK, Raman R, Rachepalli SR, Pal SS, Koluthungan V, Lakshmipathy P, Satagopan U, Kumaramanikavel G, Sharma T (2010) Anemia and diabetic retinopathy in type 2 diabetes mellitus. J Assoc Physicians India 58:91–94 Rani PK, Raman R, Rachepalli SR, Pal SS, Koluthungan V, Lakshmipathy P, Satagopan U, Kumaramanikavel G, Sharma T (2010) Anemia and diabetic retinopathy in type 2 diabetes mellitus. J Assoc Physicians India 58:91–94
3.
Zurück zum Zitat Shorb SR (1985) Anemia and diabetic retinopathy. Am J Ophthalmol 100(3):434–436CrossRef Shorb SR (1985) Anemia and diabetic retinopathy. Am J Ophthalmol 100(3):434–436CrossRef
4.
Zurück zum Zitat Soro-Paavonen A, Forbes JM (2006) Novel therapeutics for diabetic micro and macrovascular complications. Curr Med Chem 13:1777–1788CrossRef Soro-Paavonen A, Forbes JM (2006) Novel therapeutics for diabetic micro and macrovascular complications. Curr Med Chem 13:1777–1788CrossRef
5.
Zurück zum Zitat Mohamed Q, Gillies MC, Wong TY (2007) Management of diabetic retinopathy: a systematic review. JAMA 298:902–916CrossRef Mohamed Q, Gillies MC, Wong TY (2007) Management of diabetic retinopathy: a systematic review. JAMA 298:902–916CrossRef
6.
Zurück zum Zitat Simó R, Hernández C (2009) Advances in the medical treatment of diabetic retinopathy. Diabetes Care 32:1556–1562CrossRef Simó R, Hernández C (2009) Advances in the medical treatment of diabetic retinopathy. Diabetes Care 32:1556–1562CrossRef
7.
Zurück zum Zitat Simó R, Hernández C (2008) Intravitreous anti-VEGF for diabetic retinopathy: hopes and fears for a new therapeutic strategy. Diabetologia 51:1574–1580CrossRef Simó R, Hernández C (2008) Intravitreous anti-VEGF for diabetic retinopathy: hopes and fears for a new therapeutic strategy. Diabetologia 51:1574–1580CrossRef
8.
Zurück zum Zitat Joussen AM, Joeres S (2007) Benefits and limitations in vitreoretinal surgery for proliferative diabetic retinopathy and macular edema. Dev Ophthalmol 39:69–87CrossRef Joussen AM, Joeres S (2007) Benefits and limitations in vitreoretinal surgery for proliferative diabetic retinopathy and macular edema. Dev Ophthalmol 39:69–87CrossRef
9.
Zurück zum Zitat Zhang K, Ferreyra HA, Grob S, Bedell M, Zhang JJ (2013) Diabetic retinopathy: genetics and etiologic mechanisms. In: Ryan SJ (ed) Retina, 5th edn. Elsevier Saunders, China, pp 925–939CrossRef Zhang K, Ferreyra HA, Grob S, Bedell M, Zhang JJ (2013) Diabetic retinopathy: genetics and etiologic mechanisms. In: Ryan SJ (ed) Retina, 5th edn. Elsevier Saunders, China, pp 925–939CrossRef
10.
Zurück zum Zitat Wiley HE, Ferris FL III (2013) Non proliferative diabetic retinopathy and diabetic macular edema. In: Ryan SJ (ed) Retina, 5th edn. Elsevier Saunders, China, pp 940–968CrossRef Wiley HE, Ferris FL III (2013) Non proliferative diabetic retinopathy and diabetic macular edema. In: Ryan SJ (ed) Retina, 5th edn. Elsevier Saunders, China, pp 940–968CrossRef
11.
Zurück zum Zitat Silva PAS, Cavallerano JD, Sun JK et al (2013) Proliferative diabetic retinopathy. In: Ryan SJ (ed) Retina, 5th edn. Elsevier Saunders, China, pp 969–1000CrossRef Silva PAS, Cavallerano JD, Sun JK et al (2013) Proliferative diabetic retinopathy. In: Ryan SJ (ed) Retina, 5th edn. Elsevier Saunders, China, pp 969–1000CrossRef
12.
Zurück zum Zitat Wilkinson- Berka JL (2006) Angiotensin and diabetic retinopathy. Int J Biochem Cell Biol 38(5–6):752–765CrossRef Wilkinson- Berka JL (2006) Angiotensin and diabetic retinopathy. Int J Biochem Cell Biol 38(5–6):752–765CrossRef
13.
Zurück zum Zitat Wright AD, Dodson PM (2010) Diabetic retinopathy and blockade of the renin- angiotensin system: new data from the DIRECT study programme. Eye 24(1):1–6CrossRef Wright AD, Dodson PM (2010) Diabetic retinopathy and blockade of the renin- angiotensin system: new data from the DIRECT study programme. Eye 24(1):1–6CrossRef
14.
Zurück zum Zitat Sjoli AK, Dodson P, Hobbs FRR (2011) Does renin-angiotensin system blockade have a role in preventing diabetic retinopathy? A clinical review. Int J Clin Pract 65(2):148–153CrossRef Sjoli AK, Dodson P, Hobbs FRR (2011) Does renin-angiotensin system blockade have a role in preventing diabetic retinopathy? A clinical review. Int J Clin Pract 65(2):148–153CrossRef
15.
Zurück zum Zitat Rema M, Srivastava BK, Anitha B, Deepa R, Mohan V (2006) Association of serum lipids with diabetic retinopathy in urban South Indians- the Chennai Urban Rural Epidemiology Study (CURES) Eye Study-2. Diabet Med 23:1029–1036CrossRef Rema M, Srivastava BK, Anitha B, Deepa R, Mohan V (2006) Association of serum lipids with diabetic retinopathy in urban South Indians- the Chennai Urban Rural Epidemiology Study (CURES) Eye Study-2. Diabet Med 23:1029–1036CrossRef
16.
Zurück zum Zitat Alex AA, Adinortey MB, Lartey S, Amponsah I, Boadi- Kusi SB, Kyei S, Ocansey S, Abu EK, Banahene FO, Okoh C (2014) Is there any association between serum lipids and diabetic retinopathy in type 2 diabetic patients in Ghana? Int J Trop Dis Health 4(4):457–468CrossRef Alex AA, Adinortey MB, Lartey S, Amponsah I, Boadi- Kusi SB, Kyei S, Ocansey S, Abu EK, Banahene FO, Okoh C (2014) Is there any association between serum lipids and diabetic retinopathy in type 2 diabetic patients in Ghana? Int J Trop Dis Health 4(4):457–468CrossRef
17.
Zurück zum Zitat Ferris FL III, Patz A (1984) Macular edema: a complication of diabetic retinopathy. Surv Ophthalmol 28:452–461CrossRef Ferris FL III, Patz A (1984) Macular edema: a complication of diabetic retinopathy. Surv Ophthalmol 28:452–461CrossRef
18.
Zurück zum Zitat Solomon YC (1979) Diabetic retinopathy and carbohydrate metabolism. Proc Nutr Soc 38:351–358CrossRef Solomon YC (1979) Diabetic retinopathy and carbohydrate metabolism. Proc Nutr Soc 38:351–358CrossRef
19.
Zurück zum Zitat Elshazly LH, Samy N, Sebaay FE (2010) Risk factors association with diabetic retinopathy and maculopathy in Egyptian type 2 diabetics. Aust J Basic Appl Sci 4(12):6233–6238 Elshazly LH, Samy N, Sebaay FE (2010) Risk factors association with diabetic retinopathy and maculopathy in Egyptian type 2 diabetics. Aust J Basic Appl Sci 4(12):6233–6238
20.
Zurück zum Zitat Roy MS, Stables G, Collier B, Roy A, Bou E (1989) Nutritional factors in diabetics with and without retinopathy. Am J Clin Nutr 50:728–730 Roy MS, Stables G, Collier B, Roy A, Bou E (1989) Nutritional factors in diabetics with and without retinopathy. Am J Clin Nutr 50:728–730
21.
Zurück zum Zitat Krajcovicova-Kudlackova M, Sebekova K, Schinzel R, Klvanova J (2002) Advanced glycation end products and nutrition. Physiol Res 51:313–316 Krajcovicova-Kudlackova M, Sebekova K, Schinzel R, Klvanova J (2002) Advanced glycation end products and nutrition. Physiol Res 51:313–316
22.
Zurück zum Zitat Williams JH, Patel P, Jelfs R, Carter RD, Awdry P, Bron A, Mann JI, Hockaday TDR (1985) Polyunsaturated fatty acids and diabetic retinopathy. Br J Ophthalmol 69:15–18CrossRef Williams JH, Patel P, Jelfs R, Carter RD, Awdry P, Bron A, Mann JI, Hockaday TDR (1985) Polyunsaturated fatty acids and diabetic retinopathy. Br J Ophthalmol 69:15–18CrossRef
23.
Zurück zum Zitat Willet W, Manson J, Liu S (2002) Glycemic index, glycemic load and risk of type 2 diabetes. Am J Clin Nutr 76(suppl):274S–280S Willet W, Manson J, Liu S (2002) Glycemic index, glycemic load and risk of type 2 diabetes. Am J Clin Nutr 76(suppl):274S–280S
24.
Zurück zum Zitat Cummings JH, Englyst HN (1987) Fermentation in the human large intestine and the available substrates. Am J Clin Nutr 45:1243–1255 Cummings JH, Englyst HN (1987) Fermentation in the human large intestine and the available substrates. Am J Clin Nutr 45:1243–1255
25.
Zurück zum Zitat Tanaka S, Yoshimura Y, Kawasaki R, Kamada C, Tanaka S, Horikawa C, Ohashi Y, Araki A, Ito H, Akanuma Y et al (2013) Fruit intake and incident diabetic retinopathy with type 2 diabetes. Epidemiology 24(2):204–211CrossRef Tanaka S, Yoshimura Y, Kawasaki R, Kamada C, Tanaka S, Horikawa C, Ohashi Y, Araki A, Ito H, Akanuma Y et al (2013) Fruit intake and incident diabetic retinopathy with type 2 diabetes. Epidemiology 24(2):204–211CrossRef
26.
Zurück zum Zitat Fujii H, Iwase M, Okhuma T, Ogata-Kaizu S, Ide H, Kikuchi Y, Idewaki Y, Joudai T, Hirakawa Y, Uchida K et al (2013) Impact of dietary fiber intake on glycemic control, cardiovascular risk factors and chronic kidney disease in Japanese patients with type 2 diabetes mellitus: the Fukuoka Diabetes Registry. Nutr J 12:159CrossRef Fujii H, Iwase M, Okhuma T, Ogata-Kaizu S, Ide H, Kikuchi Y, Idewaki Y, Joudai T, Hirakawa Y, Uchida K et al (2013) Impact of dietary fiber intake on glycemic control, cardiovascular risk factors and chronic kidney disease in Japanese patients with type 2 diabetes mellitus: the Fukuoka Diabetes Registry. Nutr J 12:159CrossRef
27.
Zurück zum Zitat Ganesan S, Raman R, Kulothungan V, Sharma T (2012) Influence of dietary-fibre intake on diabetes and diabetic retinopathy: Sankara Nethralaya-Diabetic Retinopathy Epidemiology and Molecular Genetic Study (report 26). Clin Experiment Ophthalmol 40(3):288–294CrossRef Ganesan S, Raman R, Kulothungan V, Sharma T (2012) Influence of dietary-fibre intake on diabetes and diabetic retinopathy: Sankara Nethralaya-Diabetic Retinopathy Epidemiology and Molecular Genetic Study (report 26). Clin Experiment Ophthalmol 40(3):288–294CrossRef
28.
Zurück zum Zitat Campbell AP, Rains TM (2015) Dietary protein is important in the practical management of prediabetes and type 2 diabetes. J Nutr 145(1):164S–169SCrossRef Campbell AP, Rains TM (2015) Dietary protein is important in the practical management of prediabetes and type 2 diabetes. J Nutr 145(1):164S–169SCrossRef
29.
Zurück zum Zitat Gannon MC, Nuttall FQ (2004) Effect of a high protein, low carbohydrate diet on blood glucose control in people with type 2 diabetes. Diabetes 53:2375–2382CrossRef Gannon MC, Nuttall FQ (2004) Effect of a high protein, low carbohydrate diet on blood glucose control in people with type 2 diabetes. Diabetes 53:2375–2382CrossRef
30.
Zurück zum Zitat Pasantes-Morales H, Klethi J, Ledig M, Mandel P (1972) Free amino acids of chicken and rat retina. Brain Res 41(2):494–497CrossRef Pasantes-Morales H, Klethi J, Ledig M, Mandel P (1972) Free amino acids of chicken and rat retina. Brain Res 41(2):494–497CrossRef
31.
Zurück zum Zitat Ito T, Schaffer SW, Azuma J (2012) The potential usefulness of taurine on diabetes mellitus and its complications. Amino Acids 42:1529–1539CrossRef Ito T, Schaffer SW, Azuma J (2012) The potential usefulness of taurine on diabetes mellitus and its complications. Amino Acids 42:1529–1539CrossRef
32.
Zurück zum Zitat Obrosova IG, Minchenko AG, Marinescu V, Fathallah L, Kennedy A, Stockert CM, Frank RN, Stevens MJ (2001) Antioxidants attenuate early up regulation of retinal vascular endothelial growth factor in streptozotocin-diabetic rats. Diabetologia 44(9):1102–1110CrossRef Obrosova IG, Minchenko AG, Marinescu V, Fathallah L, Kennedy A, Stockert CM, Frank RN, Stevens MJ (2001) Antioxidants attenuate early up regulation of retinal vascular endothelial growth factor in streptozotocin-diabetic rats. Diabetologia 44(9):1102–1110CrossRef
33.
Zurück zum Zitat Nandhini AT, Thirunavukkarasu V, Anuradha CV (2004) Stimulation of glucose utilization and inhibition of protein glycation and AGE products by taurine. Acta Physiol Scand 181(3):297–303CrossRef Nandhini AT, Thirunavukkarasu V, Anuradha CV (2004) Stimulation of glucose utilization and inhibition of protein glycation and AGE products by taurine. Acta Physiol Scand 181(3):297–303CrossRef
34.
Zurück zum Zitat Yu X, Xu Z, Mi M, Xu H, Zhu J, Wei N, Chen K, Zhang Q, Zeng K, Wang J et al (2008) Dietary taurine supplementation ameliorates diabetic retinopathy via anti-excitotoxicity of glutamate in streptozotocin-induced Sprague-Dawley rats. Neurochem Res 33(3):500–507CrossRef Yu X, Xu Z, Mi M, Xu H, Zhu J, Wei N, Chen K, Zhang Q, Zeng K, Wang J et al (2008) Dietary taurine supplementation ameliorates diabetic retinopathy via anti-excitotoxicity of glutamate in streptozotocin-induced Sprague-Dawley rats. Neurochem Res 33(3):500–507CrossRef
35.
Zurück zum Zitat Lyon TJ, Jenkins AJ, Zheng D, Lackland DT, McGee D, Garvey WT, Klein RL, The DCCT/EDIC research group (2004) Diabetic retinopathy and serum lipoprotein subclasses in the DCCT/EDIC cohort. Invest Ophthalmol Vis Sci 45(3):910–918CrossRef Lyon TJ, Jenkins AJ, Zheng D, Lackland DT, McGee D, Garvey WT, Klein RL, The DCCT/EDIC research group (2004) Diabetic retinopathy and serum lipoprotein subclasses in the DCCT/EDIC cohort. Invest Ophthalmol Vis Sci 45(3):910–918CrossRef
36.
Zurück zum Zitat Eck WFV (1959) The effect of a fat diet on the serum lipids in diabetes and its significance in diabetic retinopathy. Am J Med 27(2):196–211CrossRef Eck WFV (1959) The effect of a fat diet on the serum lipids in diabetes and its significance in diabetic retinopathy. Am J Med 27(2):196–211CrossRef
37.
Zurück zum Zitat King RC, Dobree JH, Kok DA, Foulds WS, Dangerfield WG (1963) Exudatives diabetic retinopathy. Spontaneous changes and effects of a corn oil diet. Brit J Ophthal 47:666–672CrossRef King RC, Dobree JH, Kok DA, Foulds WS, Dangerfield WG (1963) Exudatives diabetic retinopathy. Spontaneous changes and effects of a corn oil diet. Brit J Ophthal 47:666–672CrossRef
38.
Zurück zum Zitat Packer L, Kraemer K, Rimbach G (2001) Molecular aspects of lipoic acid in the prevention of diabetes complications. Nutrition 17:888–895CrossRef Packer L, Kraemer K, Rimbach G (2001) Molecular aspects of lipoic acid in the prevention of diabetes complications. Nutrition 17:888–895CrossRef
39.
Zurück zum Zitat Packer L, Witt E, Tritchler H (1995) Alpha-lipoic acid as a biological antioxidant. Free Radic Biol Med 19:227–250CrossRef Packer L, Witt E, Tritchler H (1995) Alpha-lipoic acid as a biological antioxidant. Free Radic Biol Med 19:227–250CrossRef
40.
Zurück zum Zitat Kowluru RA, Odenbach S (2004) Effect of long term administration of alpha lipoic acid on retinal capillary cell death and the development of retinopathy in diabetic rats. Diabetes 53:3233–3238CrossRef Kowluru RA, Odenbach S (2004) Effect of long term administration of alpha lipoic acid on retinal capillary cell death and the development of retinopathy in diabetic rats. Diabetes 53:3233–3238CrossRef
41.
Zurück zum Zitat Lin J, Bierhaus A, Bugert P, Dietrich N, Feng Y, Vom Hagen F, Nawroth P, Brownlee M, Hammes HP (2006) Effect of R-(+)- alpha-lipoic acid on experimental diabetic retinopathy. Diabetologia 49:1089–1096CrossRef Lin J, Bierhaus A, Bugert P, Dietrich N, Feng Y, Vom Hagen F, Nawroth P, Brownlee M, Hammes HP (2006) Effect of R-(+)- alpha-lipoic acid on experimental diabetic retinopathy. Diabetologia 49:1089–1096CrossRef
42.
Zurück zum Zitat Chidlow G, Schmidt KG, Wood J, Melena J, Osborne N (2002) Alpha lipoic acid protects the retina against ischaemia-reperfusion. Neuropharmacology 43:1015–1025CrossRef Chidlow G, Schmidt KG, Wood J, Melena J, Osborne N (2002) Alpha lipoic acid protects the retina against ischaemia-reperfusion. Neuropharmacology 43:1015–1025CrossRef
43.
Zurück zum Zitat Tikhonenko M, Lydic TA, Opreanu M, Li Calzi S, Bozack S, McSorley KM, Sochacki AL, Faber MS, Hazra S, Duclos S et al (2013) N-3 polyunsaturated fatty acids prevent diabetic retinopathy by inhibition of retinal vascular damage and enhanced endothelial progenitor cell reparative function. PLoS One 8(1):e55177CrossRef Tikhonenko M, Lydic TA, Opreanu M, Li Calzi S, Bozack S, McSorley KM, Sochacki AL, Faber MS, Hazra S, Duclos S et al (2013) N-3 polyunsaturated fatty acids prevent diabetic retinopathy by inhibition of retinal vascular damage and enhanced endothelial progenitor cell reparative function. PLoS One 8(1):e55177CrossRef
44.
Zurück zum Zitat Sapieha P, Chen J, Stahl A, Seaward MR, Favazza TL, Juan AM, Hatton CJ, Joyal JS, Krah NM, Dennison RJ et al (2012) Omega-3 polyunsaturated fatty acids preserve retinal function in type 2 diabetic mice. Nutr. Diabetes 2:e36 Sapieha P, Chen J, Stahl A, Seaward MR, Favazza TL, Juan AM, Hatton CJ, Joyal JS, Krah NM, Dennison RJ et al (2012) Omega-3 polyunsaturated fatty acids preserve retinal function in type 2 diabetic mice. Nutr. Diabetes 2:e36
45.
Zurück zum Zitat Shen J, Bi YL, Das UN (2014) Potential role of polyunsaturated fatty acids in diabetic retinopathy. Arch. Med Sci 10(6):1167–1174 Shen J, Bi YL, Das UN (2014) Potential role of polyunsaturated fatty acids in diabetic retinopathy. Arch. Med Sci 10(6):1167–1174
46.
Zurück zum Zitat Koto T, Nagai N, Mochimaru H, Kurihara T, Izumi-Nagai K, Satofuka S, Shinoda H, Noda K, Ozawa Y, Inoue M et al (2007) EPA is anti-inflammatory in preventing choroidal neovascularization in mice. Invest Ophthalmol Vis Sci 48(9):4328–4334CrossRef Koto T, Nagai N, Mochimaru H, Kurihara T, Izumi-Nagai K, Satofuka S, Shinoda H, Noda K, Ozawa Y, Inoue M et al (2007) EPA is anti-inflammatory in preventing choroidal neovascularization in mice. Invest Ophthalmol Vis Sci 48(9):4328–4334CrossRef
47.
Zurück zum Zitat Querques G, Forte R, Souied EH (2011) Retina and omega-3. J Nutr Metab 2011:748361CrossRef Querques G, Forte R, Souied EH (2011) Retina and omega-3. J Nutr Metab 2011:748361CrossRef
48.
Zurück zum Zitat Osman ZM, Gomaa AM, Hussein HM Soliman, El-Shobaki AF (2004) Association between retinol metabolism and diabetic retinopathy. Pol J Food Nutr Sci 13/54(4):391–396 Osman ZM, Gomaa AM, Hussein HM Soliman, El-Shobaki AF (2004) Association between retinol metabolism and diabetic retinopathy. Pol J Food Nutr Sci 13/54(4):391–396
49.
Zurück zum Zitat Schonfeld CL (2000) All-trans-retinol (atR) inhibits expression of the metalloproteinase stromelysin in retinal pigment epithelium (RPE). Ophthalmologe 97:532–536CrossRef Schonfeld CL (2000) All-trans-retinol (atR) inhibits expression of the metalloproteinase stromelysin in retinal pigment epithelium (RPE). Ophthalmologe 97:532–536CrossRef
50.
Zurück zum Zitat Smolek MK, Notaroberto NF, Jaramillo AG, Pradillo LR (2013) Intervention with vitamins in patients with nonproliferative diabetic retinopathy: a pilot study. Clin Ophthalmol 7:1451–1458CrossRef Smolek MK, Notaroberto NF, Jaramillo AG, Pradillo LR (2013) Intervention with vitamins in patients with nonproliferative diabetic retinopathy: a pilot study. Clin Ophthalmol 7:1451–1458CrossRef
51.
Zurück zum Zitat Satyanarayana A, Balakrishna N, Pitla S, Reddy PY, Mudili S, Lopamudra P, Suryanarayana P, Viswanath K, Ayyagari R, Reddy GB (2011) Status of B vitamins and homocysteine in diabetic retinopathy: association with vitamin B12 deficiency and hyperhomocysteinemia. PLoS One 6(11):e26747CrossRef Satyanarayana A, Balakrishna N, Pitla S, Reddy PY, Mudili S, Lopamudra P, Suryanarayana P, Viswanath K, Ayyagari R, Reddy GB (2011) Status of B vitamins and homocysteine in diabetic retinopathy: association with vitamin B12 deficiency and hyperhomocysteinemia. PLoS One 6(11):e26747CrossRef
52.
Zurück zum Zitat Stitt A, Gardiner TA, Alderson NL, Canning P, Frizzell N, Duffy N, Boyle C, Januszewski AS, Chachich M, Baynes JW et al (2002) The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes. Diabetes 51:2826–2832CrossRef Stitt A, Gardiner TA, Alderson NL, Canning P, Frizzell N, Duffy N, Boyle C, Januszewski AS, Chachich M, Baynes JW et al (2002) The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes. Diabetes 51:2826–2832CrossRef
53.
Zurück zum Zitat Singer GM, Geohas J (2006) The effect of chromium picolinate and biotin supplementation on glycemic controlin poorly controlled patients with type 2 diabetes mellitus: a placebo-controlled, double-blinded, randomized trial. Diabetes Technol Ther 8(6):636–643CrossRef Singer GM, Geohas J (2006) The effect of chromium picolinate and biotin supplementation on glycemic controlin poorly controlled patients with type 2 diabetes mellitus: a placebo-controlled, double-blinded, randomized trial. Diabetes Technol Ther 8(6):636–643CrossRef
54.
Zurück zum Zitat Kern TS, Du Y, Miller CM, Hatala DA, Levin LA (2010) Overexpression of Bcl-2 in vascular endothelium inhibits the microvascular lesions of diabetic retinopathy. Am J Pathol 176:2550–2558CrossRef Kern TS, Du Y, Miller CM, Hatala DA, Levin LA (2010) Overexpression of Bcl-2 in vascular endothelium inhibits the microvascular lesions of diabetic retinopathy. Am J Pathol 176:2550–2558CrossRef
55.
Zurück zum Zitat Martin PM, Roon P, van Ells TK, Ganapathy V, Smith SB (2004) Death of retinal neurons in streptozotocin-induced diabetic mice. Invest Ophthalmol Vis Sci 45:3330–3336CrossRef Martin PM, Roon P, van Ells TK, Ganapathy V, Smith SB (2004) Death of retinal neurons in streptozotocin-induced diabetic mice. Invest Ophthalmol Vis Sci 45:3330–3336CrossRef
56.
Zurück zum Zitat Ganapathy PS, White RE, Ha Y, Bozard BR, McNeil PL, Caldwell RW, Kumar S, Black SM, Smith SB (2011) The role of N-methyl-D-aspartate receptor activation in homocysteine-induced death of retinal ganglion cells. Invest Ophthalmol Vis Sci 52:5515–5524CrossRef Ganapathy PS, White RE, Ha Y, Bozard BR, McNeil PL, Caldwell RW, Kumar S, Black SM, Smith SB (2011) The role of N-methyl-D-aspartate receptor activation in homocysteine-induced death of retinal ganglion cells. Invest Ophthalmol Vis Sci 52:5515–5524CrossRef
57.
Zurück zum Zitat Diederen RM, La Heij EC, Deutz NE, Kijlstra A, Kessels AG, van Eijk HM, Liem AT, Dieudonné S, Hendrikse F (2006) Increased glutamate levels in the vitreous of patients with retinal detachment. Exp Eye Res 83:45–50CrossRef Diederen RM, La Heij EC, Deutz NE, Kijlstra A, Kessels AG, van Eijk HM, Liem AT, Dieudonné S, Hendrikse F (2006) Increased glutamate levels in the vitreous of patients with retinal detachment. Exp Eye Res 83:45–50CrossRef
58.
Zurück zum Zitat Wijekoon EP, Brosnan ME, Brosnan JT (2007) Homocysteine metabolism in diabetes. Biochem Soc Trans 35 Wijekoon EP, Brosnan ME, Brosnan JT (2007) Homocysteine metabolism in diabetes. Biochem Soc Trans 35
59.
Zurück zum Zitat Stanger O, Herrmann W, Pietrzik K, Fowler B, Geisel J, Dierkes J, Weger M, DACH-LIGA Homocystein e.V (2003) DACH-LIGA homocystein (german, austrian and swiss homocysteine society): consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations. Clin Chem Lab Med 41:1392–1403 Stanger O, Herrmann W, Pietrzik K, Fowler B, Geisel J, Dierkes J, Weger M, DACH-LIGA Homocystein e.V (2003) DACH-LIGA homocystein (german, austrian and swiss homocysteine society): consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations. Clin Chem Lab Med 41:1392–1403
60.
Zurück zum Zitat Young I, Tate S, Lightbody J, Mcmaster D, Trimble E (1995) The effect of desferrioxamine and ascorbate on oxidative stress in the streptozotocin diabetic rat. Free Radic Biol Med 18:833–840CrossRef Young I, Tate S, Lightbody J, Mcmaster D, Trimble E (1995) The effect of desferrioxamine and ascorbate on oxidative stress in the streptozotocin diabetic rat. Free Radic Biol Med 18:833–840CrossRef
61.
Zurück zum Zitat Wilkinson I, Megson I, Maccallum H, Sogo N, Cockcroft JR, Webb DJ (1999) Oral vitamin C reduces arterial stiffness and platelet aggregation in humans. J Cardiovasc Pharmacol 34:690–693CrossRef Wilkinson I, Megson I, Maccallum H, Sogo N, Cockcroft JR, Webb DJ (1999) Oral vitamin C reduces arterial stiffness and platelet aggregation in humans. J Cardiovasc Pharmacol 34:690–693CrossRef
62.
Zurück zum Zitat Wang H, Zhang Z, Wen R, Chen J (1995) Experimental and clinical studies on the reduction of erythrocyte sorbitol-glucose ratios by ascorbic acid in diabetes mellitus. Diabetes Res Clin Pract 28:1–8CrossRef Wang H, Zhang Z, Wen R, Chen J (1995) Experimental and clinical studies on the reduction of erythrocyte sorbitol-glucose ratios by ascorbic acid in diabetes mellitus. Diabetes Res Clin Pract 28:1–8CrossRef
63.
Zurück zum Zitat Millen A, Klein R, Folsom AR, Stevens J, Patla M, Mares JA (2004) Relation between intake of vitamin C and E and risk of diabetic retinopathy in the atherosclerosis risk in Communities Study. Am J Clin Nutr 79:865–873 Millen A, Klein R, Folsom AR, Stevens J, Patla M, Mares JA (2004) Relation between intake of vitamin C and E and risk of diabetic retinopathy in the atherosclerosis risk in Communities Study. Am J Clin Nutr 79:865–873
64.
Zurück zum Zitat Baynes JW, Thorpe SR (1999) Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 48:1–9CrossRef Baynes JW, Thorpe SR (1999) Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 48:1–9CrossRef
65.
Zurück zum Zitat Sinclair AJ, Girling AJ, Gray L, Lunec J, Barnett AH (1992) An investigation of the relationship between free radical activity and vitamin C metabolism in elderly diabetic subjects with retinopathy. Gerontology 38:268–274CrossRef Sinclair AJ, Girling AJ, Gray L, Lunec J, Barnett AH (1992) An investigation of the relationship between free radical activity and vitamin C metabolism in elderly diabetic subjects with retinopathy. Gerontology 38:268–274CrossRef
66.
Zurück zum Zitat Gupta MM, Chari S (2005) Lipid peroxidation and antioxidant status in patients with diabetic retinopathy. Indian J Physiol Pharmacol 49:187–192 Gupta MM, Chari S (2005) Lipid peroxidation and antioxidant status in patients with diabetic retinopathy. Indian J Physiol Pharmacol 49:187–192
67.
Zurück zum Zitat Taverna MJ, Selam JL, Slama G (2005) Association between a protein polymorphism in the start codon of the vitamin D receptor gene and severe diabetic retinopathy in C-peptide-negative type 1 diabetes. J Clin Endocrinol Metab 90:4803–4808CrossRef Taverna MJ, Selam JL, Slama G (2005) Association between a protein polymorphism in the start codon of the vitamin D receptor gene and severe diabetic retinopathy in C-peptide-negative type 1 diabetes. J Clin Endocrinol Metab 90:4803–4808CrossRef
68.
Zurück zum Zitat Mathieu C, Adorini L (2002) The coming age of 1,25-dihyroxyvitamin D(3) analogs as immunomodulatory agents. Trends Mol Med 8(4):174–179CrossRef Mathieu C, Adorini L (2002) The coming age of 1,25-dihyroxyvitamin D(3) analogs as immunomodulatory agents. Trends Mol Med 8(4):174–179CrossRef
69.
Zurück zum Zitat Judd SE, Tangpricha V (2011) Vitamin D therapy and cardiovascular health. Curr Hypertens Rep 13(3):187–191CrossRef Judd SE, Tangpricha V (2011) Vitamin D therapy and cardiovascular health. Curr Hypertens Rep 13(3):187–191CrossRef
70.
Zurück zum Zitat Bonakdaran S, Shoeibi N (2015) Is there any correlation between vitamin D insufficiency and diabetic retinopathy? Int J Ophthalmol 8(2):326–331 Bonakdaran S, Shoeibi N (2015) Is there any correlation between vitamin D insufficiency and diabetic retinopathy? Int J Ophthalmol 8(2):326–331
71.
Zurück zum Zitat Wilkinson-Berka JL, Wraight C, Werther G (2006) The role of growth hormone, insulin-like growth factor and somatostatin in diabetic retinopathy. Curr Med Chem 13(27):3307–3317CrossRef Wilkinson-Berka JL, Wraight C, Werther G (2006) The role of growth hormone, insulin-like growth factor and somatostatin in diabetic retinopathy. Curr Med Chem 13(27):3307–3317CrossRef
72.
Zurück zum Zitat Matilainen M, Malinen M, Saavalainen K, Carlberg C (2005) Regulation of multiple insulin-like growth factor binding protein genes by 1alpha,25-dihydroxyvitamin D3. Nucleic Acids Res 33(17):5521–5532CrossRef Matilainen M, Malinen M, Saavalainen K, Carlberg C (2005) Regulation of multiple insulin-like growth factor binding protein genes by 1alpha,25-dihydroxyvitamin D3. Nucleic Acids Res 33(17):5521–5532CrossRef
73.
Zurück zum Zitat Alvarez R, Liou G, Fong S (1987) Levels of alpha- and gamma-tocopherol in human eyes: evaluation of the possible role of IRBP in intraocular alpha-tocopherol transport. Am J Clin Nutr 46:481–487 Alvarez R, Liou G, Fong S (1987) Levels of alpha- and gamma-tocopherol in human eyes: evaluation of the possible role of IRBP in intraocular alpha-tocopherol transport. Am J Clin Nutr 46:481–487
74.
Zurück zum Zitat Bursell S, Clermont A, Aiello LP, Aiello LM, Schlossman DK, Feener EP, Laffel L, King GL (1999) High dose vitamin E supplementation normalizes retinal blood flow and creatinine clearance in patients with type 1 diabetes. Diabetes Care 22:1245–1251CrossRef Bursell S, Clermont A, Aiello LP, Aiello LM, Schlossman DK, Feener EP, Laffel L, King GL (1999) High dose vitamin E supplementation normalizes retinal blood flow and creatinine clearance in patients with type 1 diabetes. Diabetes Care 22:1245–1251CrossRef
75.
Zurück zum Zitat Mamputu JC, Renier G (2004) Advanced glycation end-products increase monocyte adhesion to retinal ECs through vascular endothelial growth factor-induced ICAM-1 expression: inhibitory effect of antioxidants. J Leukoc Biol 75:1062–1069CrossRef Mamputu JC, Renier G (2004) Advanced glycation end-products increase monocyte adhesion to retinal ECs through vascular endothelial growth factor-induced ICAM-1 expression: inhibitory effect of antioxidants. J Leukoc Biol 75:1062–1069CrossRef
76.
Zurück zum Zitat Kunisaki M, Bursell SE, Clermont AC, Ishii H, Ballas LM, Jirousek MR, Umeda F, Nawata H, King GL (1995) Vitamin E prevents diabetes-induced abnormal retinal blood flow via the diacylglycerol protein kinase C pathway. Am J Physiol 269:E239–E246 Kunisaki M, Bursell SE, Clermont AC, Ishii H, Ballas LM, Jirousek MR, Umeda F, Nawata H, King GL (1995) Vitamin E prevents diabetes-induced abnormal retinal blood flow via the diacylglycerol protein kinase C pathway. Am J Physiol 269:E239–E246
77.
Zurück zum Zitat Brazionis L, Rowley K, Itsiopoulos C, O’Dea K (2009) Plasma carotenoids and diabetic retinopathy. Br J Nutr 101:270–277CrossRef Brazionis L, Rowley K, Itsiopoulos C, O’Dea K (2009) Plasma carotenoids and diabetic retinopathy. Br J Nutr 101:270–277CrossRef
78.
Zurück zum Zitat Quadro L, Blaner WS, Salchow DJ, Vogel S, Piantedosi R, Gouras P, Freeman S, Cosma MP, Colantuoni V, Gottesman ME (1999) Impaired retinal function and vitamin A availability in mice lacking retinol-binding protein. EMBO J 18:4633–4644CrossRef Quadro L, Blaner WS, Salchow DJ, Vogel S, Piantedosi R, Gouras P, Freeman S, Cosma MP, Colantuoni V, Gottesman ME (1999) Impaired retinal function and vitamin A availability in mice lacking retinol-binding protein. EMBO J 18:4633–4644CrossRef
79.
Zurück zum Zitat Li ZZ, Lu XZ, Ma CC, Chen L (2010) Serum lycopene levels in patients with diabetic retinopathy. Eur J Ophthalmol 20(4):719–723 Li ZZ, Lu XZ, Ma CC, Chen L (2010) Serum lycopene levels in patients with diabetic retinopathy. Eur J Ophthalmol 20(4):719–723
80.
Zurück zum Zitat Hu BJ, Hu YN, Lin S, Ma WJ, Li XR (2011) Application of lutein and zeaxanthin in nonproliferative diabetic retinopathy. Int. J Ophthalmol 4(3):303–306 Hu BJ, Hu YN, Lin S, Ma WJ, Li XR (2011) Application of lutein and zeaxanthin in nonproliferative diabetic retinopathy. Int. J Ophthalmol 4(3):303–306
81.
Zurück zum Zitat Majumdar S, Srirangam R (2010) Potential of the bioflavonoids in the prevention/ treatment of ocular disorders. J Pharm Pharmacol 62:951–965CrossRef Majumdar S, Srirangam R (2010) Potential of the bioflavonoids in the prevention/ treatment of ocular disorders. J Pharm Pharmacol 62:951–965CrossRef
82.
Zurück zum Zitat Hayashi A, Weinberger A, Kim H, De Juan EJ (1997) Genistein, a protein tyrosine kinase inhibitor, ameliorates retinal degeneration after ischemia-reperfusion injury in rat. Invest Ophthalmol Vis Sci 38:1193–1202 Hayashi A, Weinberger A, Kim H, De Juan EJ (1997) Genistein, a protein tyrosine kinase inhibitor, ameliorates retinal degeneration after ischemia-reperfusion injury in rat. Invest Ophthalmol Vis Sci 38:1193–1202
83.
Zurück zum Zitat Mustata GT, Rosca M, Biemel KM, Reihl O, Smith MA, Viswanathan A, Strauch C, Du Y, Tang J, Kern TS et al (2005) Paradoxical effects of green tea (Camellia sinensis) and antioxidant vitamins in diabetic rats: improved retinopathy and renal mitochondrial defects but deterioration of collagen matrix glycoxidation and cross-linking. Diabetes 54:517–526CrossRef Mustata GT, Rosca M, Biemel KM, Reihl O, Smith MA, Viswanathan A, Strauch C, Du Y, Tang J, Kern TS et al (2005) Paradoxical effects of green tea (Camellia sinensis) and antioxidant vitamins in diabetic rats: improved retinopathy and renal mitochondrial defects but deterioration of collagen matrix glycoxidation and cross-linking. Diabetes 54:517–526CrossRef
84.
Zurück zum Zitat Silva KC, Rosales MAB, Hamassaki DE, Saito KC, Faria AM, Ribeiro PAO, Lopes di Faria JB, Lopes di Faria JM (2013) Green tea is neuroprotective in diabetic retinopathy. Invest Ophthalmol Vis Sci 54(2):1325–1336CrossRef Silva KC, Rosales MAB, Hamassaki DE, Saito KC, Faria AM, Ribeiro PAO, Lopes di Faria JB, Lopes di Faria JM (2013) Green tea is neuroprotective in diabetic retinopathy. Invest Ophthalmol Vis Sci 54(2):1325–1336CrossRef
85.
Zurück zum Zitat Zhang Q, Tang X, Lu Q, Zhang Z, Rao J, Le AD (2006) Green tea extract and (-)-epigallocatechin-3-gallate inhibit hypoxia- and serum-induced HIF-1 alpha protein accumulation and VEGF expression in human cervical carcinoma and hepatoma cells. Mol Cancer Ther 5:1227–1238CrossRef Zhang Q, Tang X, Lu Q, Zhang Z, Rao J, Le AD (2006) Green tea extract and (-)-epigallocatechin-3-gallate inhibit hypoxia- and serum-induced HIF-1 alpha protein accumulation and VEGF expression in human cervical carcinoma and hepatoma cells. Mol Cancer Ther 5:1227–1238CrossRef
86.
Zurück zum Zitat Kowluru RA, Kanwar M (2007) Effects of curcumin on retinal oxidative stress and inflammation in diabetes. Nutr Metab 4:8CrossRef Kowluru RA, Kanwar M (2007) Effects of curcumin on retinal oxidative stress and inflammation in diabetes. Nutr Metab 4:8CrossRef
87.
Zurück zum Zitat Gupta SK, Kumar B, Nag TC, Agrawal SS, Agrawal R, Agrawal P, Saxena R, Srivastava S (2011) Curcumin prevents experimental diabetic retinopathy in rats through its hypoglycemic, anti oxidant, and anti-inflammatory mechanisms. J Ocul Pharmacol Ther 27:123–130CrossRef Gupta SK, Kumar B, Nag TC, Agrawal SS, Agrawal R, Agrawal P, Saxena R, Srivastava S (2011) Curcumin prevents experimental diabetic retinopathy in rats through its hypoglycemic, anti oxidant, and anti-inflammatory mechanisms. J Ocul Pharmacol Ther 27:123–130CrossRef
88.
Zurück zum Zitat Flynn DL, Rafferty MF, Boctor AM (1986) Inhibition of 5-hydroxy-eicosatetraenoic acid (5-HETE) formation in intact human neutrophils by naturally-occurring diarylheptanoids: inhibitory activities of curcuminoids and yakuchinones. Prostaglandins Leukot Med 22:357–360CrossRef Flynn DL, Rafferty MF, Boctor AM (1986) Inhibition of 5-hydroxy-eicosatetraenoic acid (5-HETE) formation in intact human neutrophils by naturally-occurring diarylheptanoids: inhibitory activities of curcuminoids and yakuchinones. Prostaglandins Leukot Med 22:357–360CrossRef
89.
Zurück zum Zitat Huang MT, Lysz T, Ferraro T, Abidi TF, Laskin JD, Conney AH (1991) Inhibitory effects of curcumin on in vitro lipoxygenase and cyclooxygenase activities in mouse epidermis. Cancer Res 51:813–819 Huang MT, Lysz T, Ferraro T, Abidi TF, Laskin JD, Conney AH (1991) Inhibitory effects of curcumin on in vitro lipoxygenase and cyclooxygenase activities in mouse epidermis. Cancer Res 51:813–819
90.
Zurück zum Zitat Sameermahmood Z, Balasubramanyam M, Saravanan T, Rema M (2008) Curcumin modulates SDF-1alpha/CXCR4- induced migration of human retinal ECs (HRECs). Invest Ophthalmol Vis Sci 49:3305–3311CrossRef Sameermahmood Z, Balasubramanyam M, Saravanan T, Rema M (2008) Curcumin modulates SDF-1alpha/CXCR4- induced migration of human retinal ECs (HRECs). Invest Ophthalmol Vis Sci 49:3305–3311CrossRef
91.
Zurück zum Zitat Williams B, Gallacher B, Patel H, Orme C (1997) Glucose-induced protein kinase C activation regulates vascular permeability factor mRNA expression and peptide production by human vascular smooth muscle cells in vitro. Diabetes 46:1497–1503CrossRef Williams B, Gallacher B, Patel H, Orme C (1997) Glucose-induced protein kinase C activation regulates vascular permeability factor mRNA expression and peptide production by human vascular smooth muscle cells in vitro. Diabetes 46:1497–1503CrossRef
92.
Zurück zum Zitat Wang L, Sun Y, Huang K, Zheng L (2013) Curcumin, a potential therapeutic candidate for retinal diseases. Mol Nutr Food Res 57:1557–1568CrossRef Wang L, Sun Y, Huang K, Zheng L (2013) Curcumin, a potential therapeutic candidate for retinal diseases. Mol Nutr Food Res 57:1557–1568CrossRef
93.
Zurück zum Zitat Kim JH, Lee BJ, Kim JH, Yu YS, Kim KW (2009) Anti-angiogenic effect of caffeic acid on retinal neovascularization. Vascul Pharmacol 51(4):262–267CrossRef Kim JH, Lee BJ, Kim JH, Yu YS, Kim KW (2009) Anti-angiogenic effect of caffeic acid on retinal neovascularization. Vascul Pharmacol 51(4):262–267CrossRef
94.
Zurück zum Zitat Shi Y, Wu X, Gong Y, Qiu Y, Zhang H, Huang Z, Su K (2010) Protective effect of caffeic acid phenethyl ester on retinal ischemia/reperfusion injury in rats. Curr Eye Res 35(10):930–937CrossRef Shi Y, Wu X, Gong Y, Qiu Y, Zhang H, Huang Z, Su K (2010) Protective effect of caffeic acid phenethyl ester on retinal ischemia/reperfusion injury in rats. Curr Eye Res 35(10):930–937CrossRef
95.
Zurück zum Zitat Durmus M, Yilmaz HR, Uz E, Ozcelik N (2008) The effect of caffeic acid phenethyl ester (CAPE) treatment on levels of MDA, NO and antioxidant enzyme activities in retinas of streptozotocin-induced diabetic rats. Turk J Med Sci 38(6):525–530 Durmus M, Yilmaz HR, Uz E, Ozcelik N (2008) The effect of caffeic acid phenethyl ester (CAPE) treatment on levels of MDA, NO and antioxidant enzyme activities in retinas of streptozotocin-induced diabetic rats. Turk J Med Sci 38(6):525–530
96.
Zurück zum Zitat Peterson M, Simmonds MSJ (2003) Rosmarinic acid. Phytochemistry 62(2):121–125CrossRef Peterson M, Simmonds MSJ (2003) Rosmarinic acid. Phytochemistry 62(2):121–125CrossRef
97.
Zurück zum Zitat Kim JH, Lee BJ, Kim JH, Young SY, Kim MY, Kim KW (2009) Rosmarinic acid suppresses retinal neovascularization via cell cycle arrest with increase of p21WAF1 expression. Eur J Pharmacol 615(1–3):150–154CrossRef Kim JH, Lee BJ, Kim JH, Young SY, Kim MY, Kim KW (2009) Rosmarinic acid suppresses retinal neovascularization via cell cycle arrest with increase of p21WAF1 expression. Eur J Pharmacol 615(1–3):150–154CrossRef
98.
Zurück zum Zitat Huang SS, Zheng RL (2006) Rosmarinic acid inhibits angiogenesis and its mechanism of action in vitro. Cancer Lett 239(2):271–280CrossRef Huang SS, Zheng RL (2006) Rosmarinic acid inhibits angiogenesis and its mechanism of action in vitro. Cancer Lett 239(2):271–280CrossRef
99.
Zurück zum Zitat Miao X, Sun W, Miao L, Fu Y, Wang Y, Su G, Liu Q (2013) Zinc and diabetic retinopathy. J Diabetes Res 2013:425854CrossRef Miao X, Sun W, Miao L, Fu Y, Wang Y, Su G, Liu Q (2013) Zinc and diabetic retinopathy. J Diabetes Res 2013:425854CrossRef
100.
Zurück zum Zitat Prasad AS (2009) Zinc: role in immunity, oxidative stress and chronic inflammation. Curr Opin Clin Nutr Metab Care 12(6):646–652CrossRef Prasad AS (2009) Zinc: role in immunity, oxidative stress and chronic inflammation. Curr Opin Clin Nutr Metab Care 12(6):646–652CrossRef
101.
Zurück zum Zitat Duzguner V, Kaya S (2007) Effect of zinc on the lipid peroxidation and the antioxidant defense systems of the alloxan-induced diabetic rabbits. Free Radic Biol Med 42(10):1481–1486CrossRef Duzguner V, Kaya S (2007) Effect of zinc on the lipid peroxidation and the antioxidant defense systems of the alloxan-induced diabetic rabbits. Free Radic Biol Med 42(10):1481–1486CrossRef
102.
Zurück zum Zitat Moustafa SA (2004) Zinc might protect oxidative changes in the retina and pancreas at the early stage of diabetic rats. Toxicol Appl Pharmacol 201(2):149–155CrossRef Moustafa SA (2004) Zinc might protect oxidative changes in the retina and pancreas at the early stage of diabetic rats. Toxicol Appl Pharmacol 201(2):149–155CrossRef
103.
Zurück zum Zitat Sahin K, Onderci M, Tuzcu M, Ustundag B, Cikim G, Ozercan IH, Sriramoju V, Juturu V, Komorowski JR (2007) Effect of chromium on carbohydrate and lipid metabolism in a rat model of type 2 diabetes mellitus: the fat-fed, streptozotocin-treated rat. Metab Clin Exp 56:1233–1240CrossRef Sahin K, Onderci M, Tuzcu M, Ustundag B, Cikim G, Ozercan IH, Sriramoju V, Juturu V, Komorowski JR (2007) Effect of chromium on carbohydrate and lipid metabolism in a rat model of type 2 diabetes mellitus: the fat-fed, streptozotocin-treated rat. Metab Clin Exp 56:1233–1240CrossRef
104.
Zurück zum Zitat Rajah TT, Olson AL, Grammas P (2001) Differential glucose uptake in retina and brain-derived ECs. Microvasc Res 62:236–242CrossRef Rajah TT, Olson AL, Grammas P (2001) Differential glucose uptake in retina and brain-derived ECs. Microvasc Res 62:236–242CrossRef
105.
Zurück zum Zitat Puchowicz MA, Xu K, Magness D, Miller C, Lust WD, Kern TS, LaManna JC (2004) Comparison of glucose influx and blood flow in retina and brain of diabetic rats. J Cereb Blood Flow Metab 24(4):449–457CrossRef Puchowicz MA, Xu K, Magness D, Miller C, Lust WD, Kern TS, LaManna JC (2004) Comparison of glucose influx and blood flow in retina and brain of diabetic rats. J Cereb Blood Flow Metab 24(4):449–457CrossRef
106.
Zurück zum Zitat Watanabe T, Matsushima S, Okazaki M, Nagamatsu S, Hirosawa K, Uchimura H, Nakahara K (1996) Localization and ontogeny of GLUT3 expression in the rat retina. Brain Res Dev Brain Res 94(1):60–66CrossRef Watanabe T, Matsushima S, Okazaki M, Nagamatsu S, Hirosawa K, Uchimura H, Nakahara K (1996) Localization and ontogeny of GLUT3 expression in the rat retina. Brain Res Dev Brain Res 94(1):60–66CrossRef
107.
Zurück zum Zitat Klip A, Paquet MR (1990) Glucose transport and glucose transporters in muscle and their metabolic regulation. Diabetes Care 13:228–243CrossRef Klip A, Paquet MR (1990) Glucose transport and glucose transporters in muscle and their metabolic regulation. Diabetes Care 13:228–243CrossRef
108.
Zurück zum Zitat Ulas M, Orhan C, Tuzcu M, Ozercan IH, Sahin N, Gencoglu H, Komorowski JR, Sahin K (2015) Anti-diabetic potential of chromium histidinate in diabetic retinopathy rats. BMC Complement Altern Med 15:16CrossRef Ulas M, Orhan C, Tuzcu M, Ozercan IH, Sahin N, Gencoglu H, Komorowski JR, Sahin K (2015) Anti-diabetic potential of chromium histidinate in diabetic retinopathy rats. BMC Complement Altern Med 15:16CrossRef
109.
Zurück zum Zitat Jain SK, Rains JL, Croad JL (2007) Effect of chromium niacinate and chromium picolinate supplementation on lipid peroxidation, TNF-α, IL-6, CRP, glycated hemoglobin, triglycerides and cholesterol levels in blood of streptozotocin-treated diabetic rats. Free Radic Biol Med 43(8):1124–1131CrossRef Jain SK, Rains JL, Croad JL (2007) Effect of chromium niacinate and chromium picolinate supplementation on lipid peroxidation, TNF-α, IL-6, CRP, glycated hemoglobin, triglycerides and cholesterol levels in blood of streptozotocin-treated diabetic rats. Free Radic Biol Med 43(8):1124–1131CrossRef
110.
Zurück zum Zitat Mutuma S, Amuna P, Shukla H, Sumar S (1999) Chromium in food, nutrition and health—an introduction. Nutri Food Sci 2:81–88CrossRef Mutuma S, Amuna P, Shukla H, Sumar S (1999) Chromium in food, nutrition and health—an introduction. Nutri Food Sci 2:81–88CrossRef
111.
Zurück zum Zitat Ueda Y, Kanazawa S, Gong H, Miyamura N, Kitaoka T, Amemiya T (2002) The retinal pigment epithelium of Cr-deficient rats. Life Sci 71:1569–1577CrossRef Ueda Y, Kanazawa S, Gong H, Miyamura N, Kitaoka T, Amemiya T (2002) The retinal pigment epithelium of Cr-deficient rats. Life Sci 71:1569–1577CrossRef
112.
Zurück zum Zitat Tabar MB (2012) Determination of serum selenium in patients with type II diabetes mellitus. Middle East J Sci Res 12(4):433–435 Tabar MB (2012) Determination of serum selenium in patients with type II diabetes mellitus. Middle East J Sci Res 12(4):433–435
113.
Zurück zum Zitat McCarty MF (2005) The putative therapeutic value of high-dose selenium in proliferative retinopathies may reflect down-regulation of VEGF production by the hypoxic retina. Med Hypotheses 64(1):159–161CrossRef McCarty MF (2005) The putative therapeutic value of high-dose selenium in proliferative retinopathies may reflect down-regulation of VEGF production by the hypoxic retina. Med Hypotheses 64(1):159–161CrossRef
114.
Zurück zum Zitat Di Leo MA, Ghirlanda G, Silveri NG, Giardina B, Franconi F, Santini SA (2003) Potential therapeutic effect of antioxidants in experimental diabetic retina: a comparison between chronic taurine and vitamin E plus selenium supplementation. Free Radic Res 37(3):323–330CrossRef Di Leo MA, Ghirlanda G, Silveri NG, Giardina B, Franconi F, Santini SA (2003) Potential therapeutic effect of antioxidants in experimental diabetic retina: a comparison between chronic taurine and vitamin E plus selenium supplementation. Free Radic Res 37(3):323–330CrossRef
115.
Zurück zum Zitat Tuvemo T, Gebre-Medhin M (1983–1985) The role of trace elements in juvenile diabetes mellitus. Pediatrician 12(4):213–219 Tuvemo T, Gebre-Medhin M (1983–1985) The role of trace elements in juvenile diabetes mellitus. Pediatrician 12(4):213–219
116.
Zurück zum Zitat Joshi U, Raut PD, Agrawal SK, Patra PK, Maheshwari BK, Apurb M, Dhirhe TC (2011) Evaluation of serum selenium levels in patients with uncomplicated diabetes mellitus, Raipur, India. J Clin Diagn Res 5:70–73 Joshi U, Raut PD, Agrawal SK, Patra PK, Maheshwari BK, Apurb M, Dhirhe TC (2011) Evaluation of serum selenium levels in patients with uncomplicated diabetes mellitus, Raipur, India. J Clin Diagn Res 5:70–73
117.
Zurück zum Zitat McNair P, Christiansen C, Madsbad S, Lauritzen E, Faber O, Binder C, Transbol I (1978) Hypomagnesemia, a risk factor in diabetic retinopathy. Diabetes 27:1075–1077CrossRef McNair P, Christiansen C, Madsbad S, Lauritzen E, Faber O, Binder C, Transbol I (1978) Hypomagnesemia, a risk factor in diabetic retinopathy. Diabetes 27:1075–1077CrossRef
118.
Zurück zum Zitat Shivkumar K (2002) Pro-fibrogenic effect of magnesium deficiency in the cardiovascular system. Magnes Res 15:307–315 Shivkumar K (2002) Pro-fibrogenic effect of magnesium deficiency in the cardiovascular system. Magnes Res 15:307–315
119.
Zurück zum Zitat Maier JAM, Malpuech-Brugere C, Zimowska W, Rays-siguier Y, Mazur A (2004) Low magnesium promotes EC dysfunction:implications for atheroscelosis, inflammation and thrombosis. Biochem Biophys Acta 1689:3–21 Maier JAM, Malpuech-Brugere C, Zimowska W, Rays-siguier Y, Mazur A (2004) Low magnesium promotes EC dysfunction:implications for atheroscelosis, inflammation and thrombosis. Biochem Biophys Acta 1689:3–21
120.
Zurück zum Zitat Zhou Q, Olinescu RM, Kummerow FA (1999) Influence of low magnesium concentrations in the medium on the antioxidant system in cultured human arterial ECs. Magnes Res 12:19–29 Zhou Q, Olinescu RM, Kummerow FA (1999) Influence of low magnesium concentrations in the medium on the antioxidant system in cultured human arterial ECs. Magnes Res 12:19–29
121.
Zurück zum Zitat Hartwig A (2001) Role of magnesium in genomic stability. Mutat Res 475:113–121CrossRef Hartwig A (2001) Role of magnesium in genomic stability. Mutat Res 475:113–121CrossRef
122.
Zurück zum Zitat Baig MSA, Ali MS, Tejovathi B (2012) Study of serum magnesium in diabetic retinopathy. Int J Biol Res 3(4):2480–2482 Baig MSA, Ali MS, Tejovathi B (2012) Study of serum magnesium in diabetic retinopathy. Int J Biol Res 3(4):2480–2482
123.
Zurück zum Zitat Lee CTC, Gayton EL, Beulens JWJ, Flanagan DW, Adler AI (2010) Micronutrients and diabetic retinopathy. Ophthalmology 117:71–78CrossRef Lee CTC, Gayton EL, Beulens JWJ, Flanagan DW, Adler AI (2010) Micronutrients and diabetic retinopathy. Ophthalmology 117:71–78CrossRef
124.
Zurück zum Zitat Rayssignier Y (1984) Role of magnesium and potassium in the pathogenesis of arteriosclerosis. Magnesium 3:226–238 Rayssignier Y (1984) Role of magnesium and potassium in the pathogenesis of arteriosclerosis. Magnesium 3:226–238
125.
Zurück zum Zitat Garfinkel D, Garfinkel L (1988) Magnesium and regulation of carbohydrate metabolism at the molecular level. Magnesium 7(5–6):249–261 Garfinkel D, Garfinkel L (1988) Magnesium and regulation of carbohydrate metabolism at the molecular level. Magnesium 7(5–6):249–261
126.
Zurück zum Zitat Rodriguez MM, Romero FG (2003) Oral magnesium supplementation improves insulin sensitivity and metabolic control in type II diabetic subjects. Diabetes Care 26(4):1147–1152CrossRef Rodriguez MM, Romero FG (2003) Oral magnesium supplementation improves insulin sensitivity and metabolic control in type II diabetic subjects. Diabetes Care 26(4):1147–1152CrossRef
127.
Zurück zum Zitat Kanwar M, Chan PS, Kern TS, Kowluru RA (2007) Oxidative damage in the retinal mitochondria of diabetic mice: possible protection by superoxide dismutase. Invest Ophthalmol Vis Sci 48:3805–3811CrossRef Kanwar M, Chan PS, Kern TS, Kowluru RA (2007) Oxidative damage in the retinal mitochondria of diabetic mice: possible protection by superoxide dismutase. Invest Ophthalmol Vis Sci 48:3805–3811CrossRef
128.
Zurück zum Zitat Madsen-Bouterse SA, Zhong Q, Mohammad G, Ho YS, Kowluru YS (2010) Oxidative damage of mitochondrial DNA in diabetes and its protection by manganese superoxide dismutase. Free Rad Res 44(3):313–321CrossRef Madsen-Bouterse SA, Zhong Q, Mohammad G, Ho YS, Kowluru YS (2010) Oxidative damage of mitochondrial DNA in diabetes and its protection by manganese superoxide dismutase. Free Rad Res 44(3):313–321CrossRef
129.
Zurück zum Zitat Uriu-Adams JY, Keen CL (2005) Copper, oxidative stress and human health. Mol Aspects Med 26:268–298CrossRef Uriu-Adams JY, Keen CL (2005) Copper, oxidative stress and human health. Mol Aspects Med 26:268–298CrossRef
130.
Zurück zum Zitat Sindhu P, Shetty B, Sudha K, Rao G (2012) Role of redox metals, oxidative protein products and antioxidant potentials of thiols in diabetic retinopathy. J Med Biochem 31(2):126–130CrossRef Sindhu P, Shetty B, Sudha K, Rao G (2012) Role of redox metals, oxidative protein products and antioxidant potentials of thiols in diabetic retinopathy. J Med Biochem 31(2):126–130CrossRef
131.
Zurück zum Zitat Mosad A, Abou S, Yousef AA (2004) Evaluation of some biochemical changes in diabetic patients. Clinica Chemica Acta 346:161–170CrossRef Mosad A, Abou S, Yousef AA (2004) Evaluation of some biochemical changes in diabetic patients. Clinica Chemica Acta 346:161–170CrossRef
132.
Zurück zum Zitat Walter RM, Uriu-Hare JY, Olin KL, Oster MH, Anawalt BD, Critchfield JW, Keen CL (1991) Copper, zinc, manganese and magnesium status and complications of diabetes mellitus. Diabetes Care 14(11):1050–1056CrossRef Walter RM, Uriu-Hare JY, Olin KL, Oster MH, Anawalt BD, Critchfield JW, Keen CL (1991) Copper, zinc, manganese and magnesium status and complications of diabetes mellitus. Diabetes Care 14(11):1050–1056CrossRef
133.
Zurück zum Zitat Singh R, Gupta V, Gupta A, Bhansali A (2005) Spontaneous closure of microaneurysms in diabetic retinopathy with treatment of co-existing anaemia. Br J Ophthalmol 89:248–249CrossRef Singh R, Gupta V, Gupta A, Bhansali A (2005) Spontaneous closure of microaneurysms in diabetic retinopathy with treatment of co-existing anaemia. Br J Ophthalmol 89:248–249CrossRef
134.
Zurück zum Zitat He BB, Wei L, Gu YJ, Han JF, Li M, Liu YX, Bao YQ, Jia WP (2012) Factors associated with diabetic retinopathy in Chinese patients with type 2 diabetes mellitus. Int J Endocrinol 2012:157940CrossRef He BB, Wei L, Gu YJ, Han JF, Li M, Liu YX, Bao YQ, Jia WP (2012) Factors associated with diabetic retinopathy in Chinese patients with type 2 diabetes mellitus. Int J Endocrinol 2012:157940CrossRef
135.
Zurück zum Zitat Friedman E, Brown C, Berman D (1995) Erythropoietin in diabetic macular edema and renal insufficiency. Am J Kidney Dis 26:202–208CrossRef Friedman E, Brown C, Berman D (1995) Erythropoietin in diabetic macular edema and renal insufficiency. Am J Kidney Dis 26:202–208CrossRef
136.
Zurück zum Zitat Guralnik JM, Eisenstaedt, Ferrucci L, Klein HG, Woodman RC (2004) Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia. Blood 104:2263–2268CrossRef Guralnik JM, Eisenstaedt, Ferrucci L, Klein HG, Woodman RC (2004) Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia. Blood 104:2263–2268CrossRef
137.
Zurück zum Zitat Ciudin A, Hernandez C, Simo R (2010) Iron overload in diabetic retinopathy: a cause or a consequence of impaired mechanisms? Exp Diabetes Res 2010:714108CrossRef Ciudin A, Hernandez C, Simo R (2010) Iron overload in diabetic retinopathy: a cause or a consequence of impaired mechanisms? Exp Diabetes Res 2010:714108CrossRef
138.
Zurück zum Zitat Roy MS, Janal MN (2010) High caloric and sodium intakes as risk factors for progression of retinopathy in type 1 diabetes mellitus. Arch Ophthalmol 128(1):33–39CrossRef Roy MS, Janal MN (2010) High caloric and sodium intakes as risk factors for progression of retinopathy in type 1 diabetes mellitus. Arch Ophthalmol 128(1):33–39CrossRef
139.
Zurück zum Zitat Tomic M, Ljubic S, Kastelan S, Antunica AG, Jazbec A, Poljicanin T (2013) Inflammation, homeostatic disturbance and obesity: possible link to pathogenesis of diabetic retinopathy in type 2 diabetes. Mediators Inflamm 2013:818671CrossRef Tomic M, Ljubic S, Kastelan S, Antunica AG, Jazbec A, Poljicanin T (2013) Inflammation, homeostatic disturbance and obesity: possible link to pathogenesis of diabetic retinopathy in type 2 diabetes. Mediators Inflamm 2013:818671CrossRef
140.
Zurück zum Zitat Katusic D, Tomic M, Jukic T, Kordic R, Sikic J, Vukojevic N, Saric B (2005) Obesity-a risk factor for diabetic retinopathy in type 2 diabetes? Coll Antropol 29(1):47–50 Katusic D, Tomic M, Jukic T, Kordic R, Sikic J, Vukojevic N, Saric B (2005) Obesity-a risk factor for diabetic retinopathy in type 2 diabetes? Coll Antropol 29(1):47–50
141.
Zurück zum Zitat Dirani M, Xie J, Fenwick E, Benarous R, Rees G, Wong TY, Lamoureux EL (2011) Are obesity and anthropometry risk factors for diabetic retinopathy? The diabetes management project. Invest Ophthalmol Vis Sci 52(7):4416–4421CrossRef Dirani M, Xie J, Fenwick E, Benarous R, Rees G, Wong TY, Lamoureux EL (2011) Are obesity and anthropometry risk factors for diabetic retinopathy? The diabetes management project. Invest Ophthalmol Vis Sci 52(7):4416–4421CrossRef
142.
Zurück zum Zitat Raman R, Rani PK, Gnanamoorthy P, Sudhir RR, Kumaramanikavel G, Sharma T (2010) Association of obesity with diabetic retinopathy: Sankara nethralaya diabetic retinopathy epidemiology and molecular genetics study (SN-DREAMS Report no. 8). Acta Diabetol 47(3):209–215CrossRef Raman R, Rani PK, Gnanamoorthy P, Sudhir RR, Kumaramanikavel G, Sharma T (2010) Association of obesity with diabetic retinopathy: Sankara nethralaya diabetic retinopathy epidemiology and molecular genetics study (SN-DREAMS Report no. 8). Acta Diabetol 47(3):209–215CrossRef
143.
Zurück zum Zitat Dowse G, Humphrey ARG, Collins VR, Plehwe W, Gareeboo H, Fareed D, Hemraj F, Taylor HR, Tuomilehto J, Alberti KG et al (1998) Prevalence and risk factors for diabetic retinopathy in the multiethnic population of Mauritius. Am J Epidemiol 147(5):448–457CrossRef Dowse G, Humphrey ARG, Collins VR, Plehwe W, Gareeboo H, Fareed D, Hemraj F, Taylor HR, Tuomilehto J, Alberti KG et al (1998) Prevalence and risk factors for diabetic retinopathy in the multiethnic population of Mauritius. Am J Epidemiol 147(5):448–457CrossRef
144.
Zurück zum Zitat Kastelan S, Tomic M, Antunica AG, Ljubic S, Rabatic JS, Karabatic M (2013) Body mass index: a risk factor for retinopathy in type 2 diabetic patients. Mediators Inflamm 2013:436329 Kastelan S, Tomic M, Antunica AG, Ljubic S, Rabatic JS, Karabatic M (2013) Body mass index: a risk factor for retinopathy in type 2 diabetic patients. Mediators Inflamm 2013:436329
145.
Zurück zum Zitat Potenza MA, Gagliardi S, Nacci C, Carratu MR, Montagnani M (2009) Endothelial dysfunction in diabetes: from mechanisms to therapeutic targets. Curr Med Chem 16(1):94–112CrossRef Potenza MA, Gagliardi S, Nacci C, Carratu MR, Montagnani M (2009) Endothelial dysfunction in diabetes: from mechanisms to therapeutic targets. Curr Med Chem 16(1):94–112CrossRef
146.
Zurück zum Zitat Klein R, Klein BEK, Moss SE (1997) Is obesity related to microvascular and macrovascular complications in diabetes? The Wisconsin epidemiologic study of diabetic retinopathy. Arch Intern Med 157(6):650–656CrossRef Klein R, Klein BEK, Moss SE (1997) Is obesity related to microvascular and macrovascular complications in diabetes? The Wisconsin epidemiologic study of diabetic retinopathy. Arch Intern Med 157(6):650–656CrossRef
147.
Zurück zum Zitat Sierra-Honigmann MR, Nath AK, Murakami C, García-Cardeña G, Papapetropoulos A, Sessa WC, Madge LA, Schechner JS, Schwabb MB, Polverini PJ et al (1998) Biological action of leptin as an angiogenic factor. Science 281(5383):P1683–P1686CrossRef Sierra-Honigmann MR, Nath AK, Murakami C, García-Cardeña G, Papapetropoulos A, Sessa WC, Madge LA, Schechner JS, Schwabb MB, Polverini PJ et al (1998) Biological action of leptin as an angiogenic factor. Science 281(5383):P1683–P1686CrossRef
148.
Zurück zum Zitat Oguz M, Kurukahvecioglu O, Salman B, Onuk E, Tatlicioglu E (2005) A subjective global assessment of nutritional status: a study of 1400 surgical patients. Gazi Tip Derg 16(2):66–69 Oguz M, Kurukahvecioglu O, Salman B, Onuk E, Tatlicioglu E (2005) A subjective global assessment of nutritional status: a study of 1400 surgical patients. Gazi Tip Derg 16(2):66–69
149.
Zurück zum Zitat Yang FL, Lee RP, Wang CH, Fang TC, Hsu BG (2007) A cohort study of subjective global assessment and mortality in Taiwanese hemodialysis patients. Ren Fail 29:1–5CrossRef Yang FL, Lee RP, Wang CH, Fang TC, Hsu BG (2007) A cohort study of subjective global assessment and mortality in Taiwanese hemodialysis patients. Ren Fail 29:1–5CrossRef
150.
Zurück zum Zitat SharmaY, Saxena S, Saxena A, Mishra A, Natu SM (2015) Interrelationship of elevated serum Advanced Glycation End- product levels and malnutrition (Subjective Global Assessment) scores with the severity of retinopathy in type II diabetes. Clin Nutr ESPEN 10:e42–e48CrossRef SharmaY, Saxena S, Saxena A, Mishra A, Natu SM (2015) Interrelationship of elevated serum Advanced Glycation End- product levels and malnutrition (Subjective Global Assessment) scores with the severity of retinopathy in type II diabetes. Clin Nutr ESPEN 10:e42–e48CrossRef
151.
Zurück zum Zitat SharmaY, Saxena S, Mishra A, Saxena A, Natu SM (2017) Apolipoprotein A-I and B and Subjective Global Assessment relationship can reflect lipid defects in diabetic retinopathy. Nutrition 33:70–75CrossRef SharmaY, Saxena S, Mishra A, Saxena A, Natu SM (2017) Apolipoprotein A-I and B and Subjective Global Assessment relationship can reflect lipid defects in diabetic retinopathy. Nutrition 33:70–75CrossRef
Metadaten
Titel
Nutrition for diabetic retinopathy: plummeting the inevitable threat of diabetic vision loss
verfasst von
Yashodhara Sharma
Sandeep Saxena
Arvind Mishra
Anita Saxena
Shankar Madhav Natu
Publikationsdatum
03.03.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Nutrition / Ausgabe 6/2017
Print ISSN: 1436-6207
Elektronische ISSN: 1436-6215
DOI
https://doi.org/10.1007/s00394-017-1406-2

Weitere Artikel der Ausgabe 6/2017

European Journal of Nutrition 6/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.